Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Related Concept Videos

Cardiovascular Drugs: Classification based on Therapeutic Indications

Cardiovascular Drugs: Classification based on Therapeutic Indications

Cardiovascular diseases, encompassing a range of conditions, can significantly affect the heart's operations and the overall circulatory system. These conditions impair the heart's ability to pump blood, leading to a deficit in oxygen supply to crucial organs. Anomalies in the heart's electrical system, known as arrhythmias, can cause heartbeats to accelerate or slow down. Usually, heart rates increase during physical activity and decrease while resting or sleeping. However,...

Regulation of the Cardiovascular System

Regulation of the Cardiovascular System

The regulation of the cardiovascular system allows the body to adapt to various demands and maintain homeostasis.
The regulation of the cardiovascular system involves the autonomic nervous system (ANS), baroreceptors, and chemoreceptors, ensuring that heart rate and blood pressure are appropriately modulated in response to varying physiological demands.
The ANS comprises two main divisions: the sympathetic and parasympathetic nervous systems. The sympathetic nervous system enhances...

Coronary Artery Disease IV: Preventive Measures

Coronary Artery Disease IV: Preventive Measures

Effective preventive measures for coronary artery disease (CAD) focus on controlling modifiable risk factors, including cholesterol abnormalities and lifestyle changes.Cholesterol ManagementFirst, the Mediterranean diet and the American Heart Association advocate for maintaining low-density lipoprotein (LDL) cholesterol levels below 100 mg/dL, with a more stringent recommendation of below 70 mg/dL for individuals at high risk. LDL cholesterol, often termed "bad cholesterol," can lead to the...

Hypertension II: Pathophysiology

Hypertension II: Pathophysiology

Hypertension is a chronic condition in which the blood's force against artery walls is excessively high, posing risks such as heart disease. The condition's underlying mechanisms involve complex interactions among the cardiovascular, kidney, and autonomic nervous systems.Renin-Angiotensin-Aldosterone System (RAAS): This system significantly influences blood pressure regulation. When blood pressure decreases, the kidneys secrete renin. This enzyme transforms angiotensinogen, a plasma protein,...

Hypertension IV: Drug Therapy and Lifestyle Modifications

Hypertension IV: Drug Therapy and Lifestyle Modifications

Multiple classes of antihypertensive medications are employed in treating hypertension. The most commonly recommended first-line treatments include:Thiazide Diuretics, such as chlorthalidone, increase sodium and water excretion from the body, reducing blood volume and blood pressure.Angiotensin-converting enzyme inhibitors, like lisinopril, block the conversion of angiotensin I to II, a potent vasoconstrictor lowering blood pressure.Angiotensin II Receptor Blockers (ARBs) prevent angiotensin II...

Atherosclerosis III: Management

Atherosclerosis III: Management

Management of atherosclerosis involves an integrated strategy encompassing pharmacological treatment, surgical interventions, lifestyle changes, and nutrition therapy to address the multifactorial nature of the disease.Pharmacological TherapyA cornerstone of atherosclerosis management is the use of pharmacological agents. Statins, such as atorvastatin, are pivotal in inhibiting HMG-CoA reductase, an enzyme that catalyzes an initial step in cholesterol synthesis in the liver. This reduction in...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

Pyoderma gangrenosum is associated with excess incident major atherothrombotic events.

Atherosclerosis·2026

Same author

Impact of residential noise pollution on early-onset myocardial infarction risk results from the DECIBEL-MI (Determination of Environmental CIty-noise's Burden, Exposure, and Link to Myocardial Infarction) study.

Clinical research in cardiology : official journal of the German Cardiac Society·2026

Same author

Socioeconomic Status and Long-Term Outcomes After ST-Segment Elevation Myocardial Infarction.

The American journal of cardiology·2026

Same author

Right atrial pressure corrected cardiac power index improves predictive power for 1-year mortality after transcatheter edge-to-edge-repair for severe tricuspid valve regurgitation.

The international journal of cardiovascular imaging·2025

Same author

Authors' reply to the comment by Zhuang and Jin on "Severe obesity in patients with ST-segment-elevation myocardial infarction (STEMI): association with age, temporal trends, and clinical outcomes."

European journal of preventive cardiology·2025

Same author

Digitoxin in Patients with Heart Failure and Reduced Ejection Fraction.

The New England journal of medicine·2025

Search research articles

Related Experiment Video

Updated: May 5, 2026

A Novel Digital Platform for a Monitored Home-based Cardiac Rehabilitation Program

A Novel Digital Platform for a Monitored Home-based Cardiac Rehabilitation Program

Published on: April 19, 2019

[Update on cardiovascular prevention 2025].

Harm Wienbergen^1,2,3, Ulrich Hanses^4,5, Hatim Kerniss^4,5

¹Bremer Institut für Herz- und Kreislaufforschung (BIHKF), Stiftung Bremer Herzen, Senator-Weßling-Str. 2, 28277, Bremen, Deutschland. harm.wienbergen@klinikum-bremen-ldw.de.

|March 28, 2025

Summary

This summary is machine-generated.

Germany

Keywords:

Cardiovascular diseases Cardiovascular prevention assistants Drugs Life style Public effort

More Related Videos

Optical Coherence Tomography Based Biomechanical Fluid-Structure Interaction Analysis of Coronary Atherosclerosis Progression

Optical Coherence Tomography Based Biomechanical Fluid-Structure Interaction Analysis of Coronary Atherosclerosis Progression

Published on: January 15, 2022

Author Spotlight: Exercise Test for Evaluation of the Functional Efficacy of the Pig Cardiovascular System

Author Spotlight: Exercise Test for Evaluation of the Functional Efficacy of the Pig Cardiovascular System

Published on: May 12, 2023

Related Experiment Videos

Last Updated: May 5, 2026

A Novel Digital Platform for a Monitored Home-based Cardiac Rehabilitation Program

A Novel Digital Platform for a Monitored Home-based Cardiac Rehabilitation Program

Published on: April 19, 2019

Optical Coherence Tomography Based Biomechanical Fluid-Structure Interaction Analysis of Coronary Atherosclerosis Progression

Optical Coherence Tomography Based Biomechanical Fluid-Structure Interaction Analysis of Coronary Atherosclerosis Progression

Published on: January 15, 2022

Author Spotlight: Exercise Test for Evaluation of the Functional Efficacy of the Pig Cardiovascular System

Author Spotlight: Exercise Test for Evaluation of the Functional Efficacy of the Pig Cardiovascular System

Published on: May 12, 2023

Area of Science:

Cardiology
Public Health
Preventive Medicine

Background:

Germany's healthcare system is expensive, yet life expectancy lags behind other nations.
Cardiovascular diseases and inadequate prevention are key factors contributing to this disparity.
A healthy lifestyle is fundamental to cardiovascular prevention, encompassing diet, exercise, and mental well-being.

Purpose of the Study:

To highlight deficits in cardiovascular prevention in Germany.
To emphasize the role of lifestyle modifications and pharmacotherapy in improving cardiovascular health.
To advocate for enhanced public and individual strategies for cardiovascular prevention.

Main Methods:

Review of current literature on cardiovascular disease risk factors and prevention strategies.
Analysis of the impact of lifestyle choices (diet, exercise, smoking, sleep, mental health) on cardiovascular outcomes.
Evaluation of the prognostic effects of modern medications like PCSK9 inhibitors, SGLT2 inhibitors, and GLP-1 receptor agonists.

Main Results:

Despite advanced medical treatments, lifestyle factors remain critical for cardiovascular health.
Specific medications (PCSK9 inhibitors, SGLT2 inhibitors, GLP-1 receptor agonists) show significant prognostic benefits.
Current cardiovascular prevention efforts in Germany are insufficient to improve life expectancy.

Conclusions:

Intensified public health initiatives are essential to improve cardiovascular prevention in Germany.
Individual patient support through trained healthcare professionals is crucial for sustainable lifestyle changes and medication adherence.
Training physicians and specialized prevention assistants is vital for effective long-term cardiovascular care.